BioN­Tech stops mak­ing cell ther­a­py at Mary­land site af­ter drop­ping germ cell tu­mor in­di­ca­tion

BioN­Tech said it’s stop­ping work on an ex­per­i­men­tal cell ther­a­py in cer­tain in­di­ca­tions, and is wind­ing down cell ther­a­py man­u­fac­tur­ing at its Gaithers­burg, MD site …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER